Merck

As HQ move nears completion, Merck finds a buyer for its sprawling Kenilworth campus
As HQ move nears completion, Merck finds a buyer for its sprawling Kenilworth campus
Fierce Pharma
Merck
New Jersey
headquarters
Flag link:
Merck seeks more approvals for infectious disease drug
Merck seeks more approvals for infectious disease drug
Endpoints
Merck
CMV
FDA
Prevymis
Flag link:
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Fierce Pharma
Merck
Keytruda
clinical trials
stomach cancer
Flag link:
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Seagen
earnings
Merck
M&A
Adcetris
Flag link:
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
Fierce Biotech
Merck
Keytruda
prostate cancer
Flag link:
Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case
Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case
Fierce Pharma
Merck
Glenmark
patents
pay-for-delay
legal
Zetia
Flag link:
Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
BioSpace
Merck
Nectin Therapeutics
NTX1088
solid tumors
Flag link:
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst
Fierce Pharma
Merck
Vertex Pharmaceuticals
Eli Lilly
pharma stocks
Flag link:
Merck Eyes Third Endometrial Cancer Nod for Keytruda
Merck Eyes Third Endometrial Cancer Nod for Keytruda
BioSpace
Merck
Keyruda
clinical trials
endometrial cancer
Flag link:
Merck pill linked to new mutations, study says
Merck pill linked to new mutations, study says
Fierce Pharma
Merck
antivirals
COVID-19
Lagevrio
Flag link:
Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials
Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials
Medical Marketing and Media
earnings
Merck
Takeda
Bristol Myers Squibb
Eli Lilly
Flag link:
The end of the Humira era
The end of the Humira era
EP Vantage
AbbVie
Humira
patents
biosimilars
Merck
Keytruda
Flag link:
Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma
Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma
Endpoints
Eli Lilly
Btk inhibitors
FDA
Merck
mantle cell lymphoma
Jaypirca
Flag link:
Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
Motley Fool
Merck
M&A
Imago BioSciences
Flag link:
Construction on Merck's London research hub set to begin in April 2023
Construction on Merck's London research hub set to begin in April 2023
Endpoints
Merck
London
R&D
UK
Flag link:
A Hit and a Miss for Merck’s Keytruda
A Hit and a Miss for Merck’s Keytruda
BioSpace
Merck
Keytruda
prostate cancer
biliary tract cancer
Flag link:
Immuno-oncology goes subcutaneous
Immuno-oncology goes subcutaneous
EP Vantage
immuno-oncology
oncology
subcutaneous drug delivery
Keytruda
Merck
Tecentriq
Roche
Flag link:
AstraZeneca, Merck go multilingual for prostate cancer push
AstraZeneca, Merck go multilingual for prostate cancer push
Medical Marketing and Media
AstraZeneca
Merck
pharma marketing
prostate cancer
Flag link:
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs
Endpoints
Merck
nitrosamine
diabetes
Januvia
Janumet
drug manufacturing
Flag link:
Biopharma's stock market winners of 2022 revealed
Biopharma's stock market winners of 2022 revealed
EP Vantage
pharma stocks
Merck
Eli Lilly
AbbVie
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Sarepta Therapeutics
Halozyme
Horizon Therapeutics
Flag link:

Pages